Recombinant hepatitis E vaccine (Lanzhou institute of biological products)
重组戊型肝炎疫苗（兰州生物制品研究所）
Report date: 2024/03/26 20:00:33
Base Information
Drug NameRecombinant hepatitis E vaccine (Lanzhou institute of biological products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesLanzhou Institute Of Biological Products Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A